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Microbial taxa distribution and density of gut microbiota habi-
tants diverge in different individuals and is modulated by
diverse determinants of temporal and spatial variability. Until
the moment of birth, the gastrointestinal (GI) tract of a nor-
mal fetus is almost sterile. During birth and thereafter, bac-
teria from mother and surrounding environment colonize the
infant’s gut by vertical and horizontal transmission. Rapidly after
the birth, bacteria start to appear in the feces in a few hours
and reach 108–1010 per gram of faeces within a few days. The
epithelium at the interface between intestinal microbiota and
lymphoid tissue plays a critical role in shaping the mucosal
immune response. When commensal/pathogenic bacteria home-
ostasis is broken up, the perturbation leads to immunological
impairment and disease, crucial in “programming early phases”
and dysbiosis establishment. Gut imbalance occurring during
perinatal and neonatal life can lead to diseases such as irri-
table bowel syndrome (IBS), early-inflammatory bowel disease
(IBD), respiratory and chronic pulmonary disease, immunolog-
ical impairment, obesity and metabolic syndrome, hence trig-
gering cardiovascular risks and nutritional impairment further
along life stages. Investigation on individuality of gut micro-
biota onset and modulation requires to speculate on genetic
and epigenetic affecting factors. Indeed, relationship between
breast feeding, gut microbial taxa, and immune system response
appears crucial in early life. However, classical microbiology is
underpowered by its inability to provide unbiased representa-
tion of gut microbiota. Failure to cultivate in vitro the majority
of microbiota taxa hampers a fulfilling description. The advent
of high-throughput-omics-based methods, through the holistic
view of the “systems biology,” is opening new avenues to the
knowledge of the gut ecosystem. In the coming years, the plasticity
of the gut microbiota will be even exploited to provide new cate-
gories of therapeutics, providing therapeutic modification of the
gut microbiota, on the basis of specific microbe-microbe modula-
tion andmicrobe-host interaction, aiming to correct and improve
life style conditions, andmedical management of chronic patients
such as cystic fibrosis-affected people. Modern microbiology may
really concur nowadays in addressing one of themost complicated
challenges of the current medicine, the achievement of effective
patient-tailored therapies to exactly depict the biology and physi-
ology of the microbiota “organ” of each person. This volume aims
to highlight several “frontiers” aspects of gut microbiota studies,
through the contribution of 12 articles describing the microbiol-
ogist’s, the “omics” people point of view, but also the clinician’s
complementary approaches coming from different expertises
and research areas, such as obstetrics, neonatology and hepato-
metabolic diseases. The first article, by Pessione (2012), presents
a spectacular overview on Lactic Acid Bacteria (LAB), ancient
microorganisms that, modulating sugar fermentation and decar-
boxylation/deimination, ensures their survival and colonization
in the buffered environments of the GI trait, by a complex molec-
ular cross-talk between LAB and host. LAB proteins, produced
in response to gut, promote bacterial adhesion to mucosa and
stimulate immune cells. Furthermore, LAB antagonistic relation-
ships with other microorganisms constitute the basis for their
anti-infective role. Thus, interesting perspectives for their utiliza-
tion as antioxidant nutraceutical vectors are hypothesized. The
second article, by Rigon et al. (2012) focuses on vertical determi-
nants of gut variability associated to vaginal or cesarean delivery
in the mother-child pair, and discuss breast- or formula feed-
ing, also thoroughly discussed in the article by Guaraldi and
Salvatori (2012). The two articles are particularly remarkable
because they focus, by employing the point of view of the clin-
ician, on the very early phases of gut microbiota programming,
still “mysterious” and difficult to be unveiled. A cluster of three
outstanding articles addresses, in a fascinating way, the gut “pro-
gramming” andmodification through life stages up to senescence
(Kolling et al., 2012; Lagier et al., 2012; Ottman et al., 2012), with
special emphasis on gut pathogens occurring during different
ages (Kolling et al., 2012), or on data obtained by metagenome,
metatranscriptome, and metaproteome integrated approaches
(Ottman et al., 2012). Interestingly, Lagier et al. (2012), intro-
duce the novel concept of “culturomics,” a breakthrough in gut
microbiota research, with the microbial identification and char-
acterization performed byMALDI-TOF technology. In the review
by Kolling et al. (2012), the process of aging is discussed in
term of changes due to environmental exposures that subse-
quently affect the immune system and host-associated micro-
biota. Within the host’s shifting setting, infections by enteric
pathogens likely exploit these shifts with resultant initiation of
pathogenesis and/or establishment of a mutualistic relationship
with the host leading to potential dissemination of the pathogen.
There is still much to be learned about how life stages and per-
turbations shape the gut microbial population, and how these
changes influence health and disease and predominant enteric
pathogens. Future insights into the interdependency between
environment-host-microbe network will be essential for devel-
opment of novel therapeutic approaches that treat or prevent
enteric disease. Understanding the roles of these factors within the
host is complementary to external approaches (e.g., sanitation,
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water treatment) for controlling or eradicating pathogen dis-
semination. The paper by Berrilli et al. (2012) strengthen the
approach undertaken by Kolling et al. (2012), on gut ecosystems
and pathogenicity and deal with the inter-play between parasites
and microbial gut ecology. The paper has been strongly desired
in the e-book Human gut microbiota: onset and shaping through
life stages and perturbations, because of the enormous novelty
of the topic, still not properly approached by the current lit-
erature. Indeed, complex communities, different from bacterial
gut ecosystems, including parasites (“parasitome”) and the even
less studied fungi (“micetome”), surely co-evolve and interact
with the gut microbiome modulating its ecology and physiol-
ogy, reacting in a different way with and against the host. Indeed,
interesting are the parasite immune-modulations at the gut ente-
rocyte level on host immune reaction. On the other site, “omics”
technology and their paramount effects on gut microbiota studies
have been also deeply described in the articles by Shen et al. (2012)
(genomics, metagenomics, and gut modifications), Vernocchi
et al. (2012), and Masotti (2012) (gene expression, transcrip-
tomics). Metabolic profiling has a wide potential to understand
the complex interactions amongst components of the gut micro-
biota and to elucidate the relationships (cause/effect) between
specific nutritional choices and related shifts in microbiota taxa
composition. Particularly, the identification of gut metabolic
signatures is extremely challenging, due to its linkage with nutri-
tional choices. In fact, the whole set of metabolites, which can
be detected in body fluids and characterizes the metabolic gut-
associated phenotypes, can be named “metabotype” (Vernocchi
et al., 2012). Dealing with a differential expression of miRNAs
in different areas of GI tract can be considered as a function
of microbiota composition. In these cases, intestinal microbiota
are the “actors.” Conversely, we should also think to miRNAs as
“actors” when, under proper conditions, influence the regulation
of goblet-cell differentiation. Therefore, an interconnected cycle
could be envisaged, as suggested by the Opinion article byMasotti
(2012), where miRNAs and gut microbiota are the two main
partners.
Finally, two remarkable papers by Alisi et al. (2012), and
Manco (2012) open new avenues on non-alcoholic fatty liver
disease (NAFLD), one of the most common causes of chronic
liver disease worldwide, and on the gut-brain axis in obesity
endophenotypes, respectively. In NAFLD, several observations
suggest a potential role of microbiota in NAFLD development,
authors suggest that probiotics, for their excellent tolerability,
may affect gut microbiota, hence representing promising thera-
peutic agents to revert NASH-related liver damage. Furthermore,
the interesting relationships between gut microbiota and devel-
opmental programming of the brain, discussed in the Opinion
article by Manco (2012), are providing unpredictable evidence
in studies on mental retardation, autism and role of gut dys-
biosis through the route to the final outcome of the overt
disease.
In summary, the articles herein presented, discuss data and
matters concerning current investigation and future perspective
on gut microbiota studies. In our opinion, further insights will
come from interdisciplinary approaches progressively provided
by enlarged consortia, including researchers and clinicians, able to
exploit high-throughput technological platforms to apply trans-
lational workflows in diagnostic pipelines and, finally, in patient
care and treatment programs.
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